Literature DB >> 8094489

Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor.

A J Clark1, L McLoughlin, A Grossman.   

Abstract

Familial glucocorticoid deficiency is an uncommon disorder that appears to be due to congenital insensitivity or resistance to adrenocorticotropin (ACTH), and is usually inherited in an autosomal recessive pattern. We investigated the DNA base sequence in a family with this condition by polymerase chain reaction amplification of DNA with pairs of primers that span the ACTH-receptor domain. The affected male proband showed a single base mutation, ser74-->ile, in the sequence coding for the second transmembrane domain of the ACTH receptor. A similar defect was found in an affected sister, a normal sequence in an unaffected brother, and both alleles in each parent. This is only the second clinical disorder associated with a GTP-binding-protein-linked hormone-receptor mutation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094489     DOI: 10.1016/0140-6736(93)90208-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  55 in total

Review 1.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

2.  SGPL1 Deficiency: A Rare Cause of Primary Adrenal Insufficiency.

Authors:  Nikolaos Settas; Rebecca Persky; Fabio R Faucz; Nicole Sheanon; Antonis Voutetakis; Maya Lodish; Louise A Metherell; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

3.  Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

Review 4.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

5.  Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling.

Authors:  Min Chen; Charles J Aprahamian; Robert A Kesterson; Carroll M Harmon; Yingkui Yang
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

6.  Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis.

Authors:  Dai Chida; Shinichi Nakagawa; So Nagai; Hiroshi Sagara; Harumi Katsumata; Toshihiro Imaki; Harumi Suzuki; Fumiko Mitani; Tadashi Ogishima; Chikara Shimizu; Hayato Kotaki; Shigeru Kakuta; Katsuko Sudo; Takao Koike; Mitsumasa Kubo; Yoichiro Iwakura
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

7.  Familial adrenocorticotropin unresponsiveness associated with alacrima and achalasia: biochemical and molecular studies in two siblings with clinical heterogeneity.

Authors:  C Heinrichs; C Tsigos; J Deschepper; R Drews; R Collu; C Dugardeyn; P Goyens; G E Ghanem; D Bosson; G P Chrousos
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

8.  Functional consequence of a novel Y129C mutation in a patient with two contradictory melanocortin-2-receptor mutations.

Authors:  Li F Chan; Teng-Teng Chung; Ahmed F Massoud; Louise A Metherell; Adrian J L Clark
Journal:  Eur J Endocrinol       Date:  2009-01-16       Impact factor: 6.664

9.  Isolated Addison's disease is unlikely to be caused by mutations in MC2R, MRAP or STAR, three genes responsible for familial glucocorticoid deficiency.

Authors:  R P Dias; L F Chan; L A Metherell; S H S Pearce; A J L Clark
Journal:  Eur J Endocrinol       Date:  2009-11-10       Impact factor: 6.664

10.  Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2.

Authors:  Teng-Teng L L Chung; Li F Chan; Louise A Metherell; Adrian J L Clark
Journal:  Clin Endocrinol (Oxf)       Date:  2009-06-24       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.